Judith Korner, Louis J. Aronne
J Clin Invest. 2003;
111(5):565
doi:10.1172/JCI17953
Citation information
This citation data is accumulated from
CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
Therapeutic potential of antiangiogenic agents for prevention and treatment of obesity
Yihai Cao, Renhai Cao, Yuan Xue
|
Future Lipidology
|
2008 |
Anti-obesity drugs
Robert F Kushner
|
Expert Opin. Pharmacother.
|
2008 |
New Targets for Obesity Pharmacotherapy
L J Aronne, Z D Thornton-Jones
|
Clin Pharmacol Ther
|
2007 |
Angiogenesis modulates adipogenesis and obesity
Yihai Cao
|
J. Clin. Invest.
|
2007 |
Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus
Shlomit Koren, I. George Fantus
|
Best Practice & Research Clinical Endocrinology & Metabolism
|
2007 |
Does weight loss prognosis depend on genetic make-up?
M. J. Moreno-Aliaga, J. L. Santos, A. Marti, J. A. Martinez
|
Obesity Reviews
|
2005 |
Gastrointestinal surgery and gut hormones
Simon Aylwin
|
Current Opinion in Endocrinology & Diabetes
|
2005 |
Prospective medicine: the role for genomics in personalized health planning
Jason M Langheier, Ralph Snyderman
|
Pharmacogenomics
|
2004 |
Nutrition and metabolism
Deepak Bhatnagar, Tara Kearney
|
Current Opinion in Lipidology
|
2003 |
The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes
Bernhard O Boehm
|
Expert Opin. Investig. Drugs
|
2003 |
